0001140361-21-011513.txt : 20210405 0001140361-21-011513.hdr.sgml : 20210405 20210405091702 ACCESSION NUMBER: 0001140361-21-011513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Martin CENTRAL INDEX KEY: 0001823380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 21803921 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 form4.xml FORM 4 X0306 4 2021-04-01 0001484612 Outset Medical, Inc. OM 0001823380 Vazquez Martin 3052 ORCHARD DRIVE SAN JOSE CA 95134 true Chief Operating Officer Common Stock 2021-04-01 4 M 0 12716 3.88 A 21971 D Common Stock 2021-04-01 4 M 0 9784 3.88 A 31755 D Common Stock 2021-04-01 4 S 0 19997 55.013 D 11758 D Common Stock 2021-04-01 4 S 0 2503 55.3625 D 9255 D Performance Stock Option (Right to Buy) 3.88 2021-04-01 4 M 0 12716 0 D 2018-09-30 2027-12-19 Common Stock 12716 0 D Performance Stock Option (Right to Buy) 3.88 2021-04-01 4 M 0 9784 0 D 2018-12-21 2027-12-19 Common Stock 9784 2932 D The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $54.23 to $55.222, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $55.23 to $55.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. This Form 4 corrects the exercise price previously reported as $3.87 on the Form 3 filed on September 14, 2020. /s/ John L. Brottem, attorney-in-fact for Martin Vazquez 2021-04-05